HBsAg levels as a guide for finite treatment duration of chronic hepatitis B

[No abstract available]

Authors
Abdurakhmanov D. 1 , Ibragimov E. 1 , Rozina T. 1 , Nikulkina E. 1 , Mazurchik N. 2
Journal
Clinics and Research in Hepatology and Gastroenterology
Publisher
Elsevier Masson SAS
Issue number
5
Language
English
Pages
e73-e75
State
Published
Link
External link
DOI
10.1016/J.CLINRE.2018.12.007
Volume
43
Year
2019
Organizations
  • 1 Sechenov First Moscow State Medical University, Moscow, Russian Federation
  • 2 RUDN University, Medicine Faculty, Moscow, Russian Federation
Keywords
HBsAg level; HBV; Nucleoside analogues; Relapse
Cite
ГОСТ MLA RIS BibTex
Share

Other records